Sabitlenmiş Tweet

Pre-clinical opportunity for new RNA modality for silencing Activin A only in muscle as a potential treatment for obesity and GLP1-RA induced muscle loss and sarcopenia. #bimagrumab #61000000Ieeq/a/Ki000001E6bU/087X0E40KlaPjUzK1Pe79TewYJ.TasZL8tpmbkKYMPk" target="_blank" rel="nofollow noopener">umassmed.my.salesforce.com/sfc/p/#6100000…
English






